Clinical Trial Update: LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the optimal dose intensity of LONSURF with G-CSF in metastatic colorectal cancer; the study is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING